Remedy Entertainment Oy · OMXHEX:REMEDY
Remedy Entertainment Oy — Q3 2023 Earnings Presentation
29 slides from Remedy Entertainment Oy's earnings presentation, Oct 31, 2023
Slide 1: Business Review January–September 2023
Business Review January–September 2023 OCTOBER 31, 2023 © REMEDY ENTERTAINMENT 2023 REMEDY CONFIDENTIAL
Slide 2: Agenda
AGENDA REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 1 Q3 2023 Review 2 Q3 2023 Financial Results 3 Outlook 4 Questions & Answers Tero Virtala CEO Terhi Kauppi CFO 2
Slide 3: Q3 2023 Review
Q3 2023 Review Tero Virtala, CEO
Slide 4: Q3 2023 Highlights
Q3 2023 HIGHLIGHTS REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 ‒ Revenue decreased by 1.1% to 7.8 M€ (7.9) ‒ EBITDA decreased to -4.2 M€ (-2.4) ‒ Operating profit -5.5 M€ (-3.0), operating profit margin -70.0% (-38.4%) ‒ Cash flow from operations -5.1 M€ (4.7) ‒ In September, the Board of Direct
Slide 5: Alan Wake 2 launched on October 27
© REMEDY ENTERTAINMENT 2023 6 REMEDY CONFIDENTIAL ALAN WAKE 2 LAUNCHED ON OCTOBER 27
Slide 6: © REMEDY ENTERTAINMENT 2023
© REMEDY ENTERTAINMENT 2023 REMEDY CONFIDENTIAL
Slide 7: Alan Wake 2: great visibility across stores
ALAN WAKE 2: GREAT VISIBILITY ACROSS STORES REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 Epic Games Store Xbox Store PlayStation Store
Slide 8: Alan Wake 2 review scores
ALAN WAKE If 10/10 10/10 10/10 10/10 10/10 10/10 10/10 10/10 Thesixthaxis Gamereactor UK GamesRadar+ XboxEra Player 2 95/10 5/5 5/5 5/5 45/5 5/5 | 5/5 | 9/0 eenRant. «= = ss )~—SSC~*~CS~*«Stertcinent Geely = TheGamer S.I/10 99/10 9.5/10 99/10 9.5/10 9/10 S/10 9/10 Press Start COGconnected Gaming Bib
Slide 9: Metacritic score of Alan Wake 2
DEDICATION AND HARD WORK REFLECTED IN THE METACRITIC SCORE OF ALAN WAKE 2 REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 Very positive overall view on the game Review success on all platforms Source: Metacritic. As of October 30, 2023
Slide 10: Current project portfolio
CURRENT PROJECT PORTFOLIO REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 Condor* Control 2 Alan Wake Alan Wake II * Max Payne * Remastered 1&2 remake LAUNCHED PRODUCTION READINESS PROOF-OF-CONCEPT LAUNCHED LAUNCHED PROOF-OF-CONCEPT PRODUCTION READINESS WITH WITH WITH WITH 13 * project codename
Slide 11: We continue to invest into our world class talent pool
WE CONTINUE TO INVEST INTO OUR WORLD CLASS TALENT POOL REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 376 2 Remedy talents* Development (September 30, 2023) studios We utilize and continue to expand external development capabilities Stockholm Helsinki * Defined as headcount added with people who wo
Slide 12: Strong basis and investments to enable sustainable long-term growth
STRONG BASIS AND INVESTMENTS TO ENABLE SUSTAINABLE LONG-TERM GROWTH REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 2023 - 2027 REMEDY in 2022 • Ability to develop new games 2017 - 2021 and live operate existing ones. • Ability to develop 5 games • Game updates, and new in parallel. game launches ev
Slide 13: Q3 2023 Financial Results
Q3 2023 Financial Results Terhi Kauppi, CFO
Slide 14: Q3 2023: Revenue flat y-o-y, royalties grew
Q3 2023: REVENUE FLAT Y-O-Y, ROYALTIES GREW Y-O-Y DRIVEN BY ALAN WAKE REMASTERED BREAKING EVEN DURING THE QUARTER REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 -1% 7.9 7.8 7.4 0.4 1.1 2.1 7.5 6.7 5.3 Q3 2021 Q3 2022 Q3 2023 Royalties (EURm) Development Fees (EURm)
Slide 15: Historical breakdown of revenue
HISTORICAL BREAKDOWN OF REVENUE REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 19.8 1.4 -1% 13.7 12.7 0.9 1.0 9.4 8.9 18.4 7.9 2.0 1.0 7.8 0.4 6.9 1.1 12.8 0.5 11.6 7.4 7.5 7.9 6.4 6.7 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Royalties (EURm) Development Fees (EURm)
Slide 16: Q3 2023: Profitability declined with own game investments
Q3 2023: PROFITABILITY DECLINED WITH OWN GAME INVESTMENTS AT A HIGHER LEVEL REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 -0.2 -2.9% -3.0 -38.4% -5.5 -70.0% Q3 2021 Q3 2022 Q3 2023 Q3 2021 Q3 2022 Q3 2023 Operating Profit (EURm) Operating Profit Margin (%)
Slide 17: Q1-Q3 2023: Investing more to finance projects
Q1-Q3 2023: REMEDY HAS BEEN INVESTING MORE TO FINANCE PROJECTS RESULTING IN LESS DEVELOPMENT FEES REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 -21% 30.0 3.4 24.9 23.6 2.5 7.3 26.6 21.1 17.6 Q1-Q3 2021 Q1-Q3 2022 Q1-Q3 2023 Royalties (EURm) Development Fees (EURm)
Slide 18: Q1-Q3 2023: Investment phase reflected on profitability
Q1-Q3 2023: INVESTMENT PHASE REFLECTED ON PROFITABILITY: LESS DEVELOPMENT FEES TO COVER DEVELOPMENT EXPENSES REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 1.1 4.3% -2.7 -9.0% -15.9 -67.1% Q1-Q3 2021 Q1-Q3 2022 Q1-Q3 2023 Q1-Q3 2021 Q1-Q3 2022 Q1-Q3 2023 Operating Profit (EURm) Operating Profit Mar
Slide 19: Q3 2023: Increase in personnel cost and external development
Q3 2023: MARGINAL Y-O-Y INCREASE IN PERSONNEL COST AND EXTERNAL DEVELOPMENT REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 2.0 2.0 2.1 2.0 1.8 1.3 1.4 1.0 -2.9 -3.6 -3.8 -4.5 -4.3 -4.9 -4.7 -4.9 -6.3 -6.5 -6.6 -6.9 -6.8 -6.9 -7.5 -7.6 Q4 2021 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Slide 20: Q3 2023: Strong cash position
Q3 2023: STRONG CASH POSITION GIVES THE BACKBONE FOR THE CURRENT INVESTMENT PHASE WITH MORE CO-FINANCED PROJECTS REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 18.0 73.4 7.0 63.3 60.4 58.4 6.8 6.8 55.9 7.0 6.8 49.7 9.9 4.7 39.0 66.4 10.1 31.7 53.6 56.5 10.0 51.4 49.0 -2.2 39.8 -3.8 -3.9 28.9 -5.1 2
Slide 21: Historical revenue and profitability profile
HISTORICAL REVENUE AND PROFITABILITY PROFILE REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 FAS IFRS 52 40% 47 44.7 43.6 9.8% 18.9% 41.1 20% 42 11.7% 6.1% 24.1% 25.5% 4.7% 20.6% 17.6% 37 31.6 0% 32 2.4% 1.7% 3.0% -1.3% 27 -20% 23.6 22 20.1 16.4 17.2 17 15.5 -40% 13.7 11.9 12 10.5 -60% 7 4.7 3.8 -67
Slide 22: Multi-project future with more games: balancing risk and reward
MULTI-PROJECT FUTURE WITH MORE GAMES: BALANCING RISK AND REWARD REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 Self-published Co-published Own IP with publishing partner Partner IP Reward possibility Risk
Slide 23: Multi-project future with more games: balancing risk and reward
MULTI-PROJECT FUTURE WITH MORE GAMES: BALANCING RISK AND REWARD REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023
Slide 24: Outlook
Outlook Tero Virtala, CEO
Slide 25: Outlook for 2023 (unchanged)
OUTLOOK FOR 2023 (UNCHANGED) REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 Remedy expects its revenue to decline from previous year and a negative operating result. In 2022, Remedy’s revenue totaled EUR 43.6 million and operating profit EUR –0.6 million.
Slide 26: Long-term objectives (unchanged)
LONG-TERM OBJECTIVES (UNCHANGED) REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 To create several To own at least three To have capabilities successful games expanding game to select the right and at least one brands, all with long- commercial model major hit game term hit potential for each game T
Slide 27: Questions & Answers
Questions & Answers
Slide 28: Q&A instructions
Q&A INSTRUCTIONS REMEDY CONFIDENTIAL © REMEDY ENTERTAINMENT 2023 ‒ Speakers will now take questions from the investors, analysts and media representatives ‒ Web participants: type in your question
Slide 29: Contact
Contact: ir@remedygames.com investors.remedygames.com RemedyGames